Sumito Shingaki
Impact in
-
- Cancer Genomics and Diagnostics
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 2
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Marni B. McClure (3 shared papers)Yuichi Shiraishi (2 shared papers)Takanori Kanai∥ (1 shared paper)Hiroko Tanaka (1 shared paper)Yasunori Kogure (4 shared papers)Mariko Tabata (4 shared papers)Shigeyuki Matsumoto (1 shared paper)Kota Yoshifuji (2 shared papers)
- Journals
- International Journal of Hematology (2 papers)Blood (1 paper)Leukemia (1 paper)Blood Advances (1 paper)Nature (1 paper)
- Partner nations
- JapanUnited KingdomSweden
In The Last Decade
Sumito Shingaki
13 papers receiving 133 citations
Peers
Comparison fields: 5 of 39
- Cancer Research 33
- Hematology 23
- Genetics 16
- Oncology 35
- Molecular Biology 87
Countries citing papers authored by Sumito Shingaki
This map shows the geographic impact of Sumito Shingaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumito Shingaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumito Shingaki more than expected).
Fields of papers citing papers by Sumito Shingaki
This network shows the impact of papers produced by Sumito Shingaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumito Shingaki. The network helps show where Sumito Shingaki may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumito Shingaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 84 | |
| 2 | 2016 | 23 | |
| 3 | 2017 | 8 | |
| 4 | 2015 | 5 | |
| 5 | 2020 | 3 | |
| 6 | 2015 | 2 | |
| 7 | Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia. | 2014 | 2 |
| 8 | 2015 | 2 | |
| 9 | 2018 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2018 | 1 | |
| 12 | 2015 | 1 | |
| 13 | Effects of sequential administration of bleomycin in combination with mitomycin C on squamous cell carcinoma of oral regions. | 1980 | 1 |
| 14 | 2025 | 0 | |
| 15 | 2020 | 0 |
About Sumito Shingaki
Sumito Shingaki is a scholar working on Hematology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 15 papers that have together received 134 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Dermatological and Skeletal Disorders (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Cancer Research (33 citations), Hematology (23 citations), Genetics (16 citations), Oncology (35 citations) and Molecular Biology (87 citations). Sumito Shingaki has collaborated with scholars based in Japan, United Kingdom and Sweden. Frequent co-authors include Marni B. McClure, Yuichi Shiraishi, Takanori Kanai∥, Hiroko Tanaka, Yasunori Kogure, Mariko Tabata, Shigeyuki Matsumoto, Kota Yoshifuji, Junji Koya and Kenshi Suzuki. Their work appears in journals such as International Journal of Hematology, Blood, Leukemia, Blood Advances and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.